GlassScriptPhysician profile
Wade Alan Graham
NPI 1316938434
$2,082.84
in general payments reported to CMS, 2019-2025
10 companies · $248 in 2025
The $248 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $292 · 2020: $358 · 2021: $140 · 2022: $310 · 2023: $286 · 2024: $449 · 2025: $248.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $983.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $983.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $723.04 | 2019-2025 | Clareon, Rocklatan, Eysuvis |
| Abbvie INC. | $474.93 | 2022-2025 | |
| Allergan, INC. | $311.35 | 2019-2021 | |
| Rxsight INC | $147.49 | 2024 | Light Adjustable Lens (Lal), Rxsight Contact Lens, Rxsight Injector Cartridge |
| Aerie Pharmaceuticals, INC. | $117.00 | 2019 | |
| Sight Sciences, INC. | $114.97 | 2023 | Tearcare System |
| Biotissue Holdings INC. | $86.62 | 2019-2023 | |
| Amgen INC. | $64.60 | 2025 | Tepezza |
| Kala Pharmaceuticals, INC. | $27.46 | 2020-2021 | |
| Thea Pharma INC. | $15.38 | 2024 | Iyuzeh |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Wade Graham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.